BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18207658)

  • 1. External beam boost for cancer of the cervix uteri when intracavitary therapy cannot be performed.
    Barraclough LH; Swindell R; Livsey JE; Hunter RD; Davidson SE
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):772-8. PubMed ID: 18207658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
    Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD; Rai B; Mallick I; Sharma SC
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical radiotherapy with high-dose-rate brachytherapy for uterine cervix cancer long-term results.
    Khor TH; Tuan JK; Hee SW; Tham IW
    Australas Radiol; 2007 Dec; 51(6):570-7. PubMed ID: 17958695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix.
    Nakano T; Kato S; Ohno T; Tsujii H; Sato S; Fukuhisa K; Arai T
    Cancer; 2005 Jan; 103(1):92-101. PubMed ID: 15540233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients.
    Chargari C; Magné N; Dumas I; Messai T; Vicenzi L; Gillion N; Morice P; Haie-Meder C
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):133-9. PubMed ID: 18774656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose rate brachytherapy using inverse planning simulated annealing for locoregionally advanced cervical cancer: a clinical report with 2-year follow-up.
    Kim DH; Wang-Chesebro A; Weinberg V; Pouliot J; Chen LM; Speight J; Littell R; Hsu IC
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1329-34. PubMed ID: 19409728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose-rate intracavitary brachytherapy for cervical carcinomas with lower vaginal infiltration.
    Kazumoto T; Kato S; Tabushi K; Kutsutani-Nakamura Y; Mizuno H; Takahashi M; Shiromizu K; Saito Y
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1157-66. PubMed ID: 17459604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy alone for invasive vaginal cancer: outcome with intracavitary high dose rate brachytherapy versus conventional low dose rate brachytherapy.
    Kucera H; Mock U; Knocke TH; Kucera E; Pötter R
    Acta Obstet Gynecol Scand; 2001 Apr; 80(4):355-60. PubMed ID: 11264612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of care and outcome in elderly cervical cancer patients: a special focus on brachytherapy.
    Magné N; Mancy NC; Chajon E; Duvillard P; Pautier P; Castaigne D; Lhommé C; Morice P; Haie-Meder C
    Radiother Oncol; 2009 May; 91(2):197-201. PubMed ID: 18954913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome for chemoradiotherapy in carcinoma of the cervix.
    Spensley S; Hunter RD; Livsey JE; Swindell R; Davidson SE
    Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):49-55. PubMed ID: 19081712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of concomitant chemoradiation for cervical cancer using high dose rate intracavitary brachytherapy: study of JROSG (Japan Radiation Oncology Study Group).
    Sakata K; Sakurai H; Suzuki Y; Katoh S; Ohno T; Toita T; Kataoka M; Tanaka E; Kaneyasu Y; Uno T; Harima Y; Nakano T;
    Acta Oncol; 2008; 47(3):434-41. PubMed ID: 18348003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
    Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H
    Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Follow-up study of clinical effects of californium-252 neutron intracavitary radiotherapy and external beam radiotherapy in endometrial cancer].
    Lei X; Shan JL; Tang C; Zhao KW
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):733-6. PubMed ID: 18307897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The preliminary report of cervical cancer treated with californium-252 neutron after loading intracavitary radiotherapy].
    Luo G; Zheng C; Shan J
    Zhonghua Fu Chan Ke Za Zhi; 2001 Dec; 36(12):742-4. PubMed ID: 16136896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early clinical outcomes of 3D-conformal radiotherapy using accelerated hyperfractionation without intracavitary brachytherapy for cervical cancer.
    Matsuura K; Tanimoto H; Fujita K; Hashimoto Y; Murakami Y; Kenjo M; Kaneyasu Y; Wadasaki K; Ito K
    Gynecol Oncol; 2007 Jan; 104(1):11-4. PubMed ID: 16890981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
    Kim YS; Kim JH; Ahn SD; Lee SW; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1522-8. PubMed ID: 19231106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma.
    Oehler-Jänne C; Seifert B; Lütolf UM; Studer G; Glanzmann C; Ciernik IF
    Brachytherapy; 2007; 6(3):218-26. PubMed ID: 17681244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated hyperfractionated radiotherapy for cervical cancer: multi-institutional prospective study of forum for nuclear cooperation in Asia among eight Asian countries.
    Ohno T; Nakano T; Kato S; Koo CC; Chansilpa Y; Pattaranutaporn P; Calaguas MJ; de Los Reyes RH; Zhou B; Zhou J; Susworo R; Supriana N; Dung TA; Ismail F; Sato S; Suto H; Kutsutani-Nakamura Y; Tsujii H
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1522-9. PubMed ID: 17919839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cervical cancer: results of an IAEA multicentre randomised trial.
    Dobrowsky W; Huigol NG; Jayatilake RS; Kizilbash NI; Okkan S; Kagiya VT; Tatsuzaki H
    Radiother Oncol; 2007 Jan; 82(1):24-9. PubMed ID: 17161478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.